Roche Diabetes Care
UEI: WJHDT127L353
Overview
Awardee Type
Parent
(3 children)
Company Description
As a pioneer in healthcare, we have been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.
Name
Roche Diabetes Care
Headquarters
Indianapolis, IN
United States
United States
Most Recent Award
May 3, 2024
Calculating
Federal contract and grant recipient
ROCHE DIAGNOSTICS CORPORATION
dba ROCHE DIAGNOSTICS CORP
(UEI WJHDT127L353)
is headquartered in Indianapolis IN.
Its primary registered NAICS is 325413 In-Vitro Diagnostic Substance Manufacturing.
The corporation
was founded in January 1979 and
federally registered in
January 2002.
Federal Award Analysis
Roche Diabetes Care federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
This Parent entity does not have an associated active registration. Showing registration information for UEI JDMDFEZBYH36 CAGE 51169 instead.
Legal Name
ROCHE DIAGNOSTICS CORPORATION
DBA
ROCHE DIAGNOSTICS CORP
UEI
JDMDFEZBYH36
CAGE Code
51169
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Jan. 1, 1979
Initial Registration
Jan. 15, 2002
Last Registration
Dec. 23, 2023
Registration Activation
Dec. 7, 2023
Registration Expiration
Nov. 19, 2024
Fiscal Year End
December 31
Reported Entity Types
Foreign Owned
For Profit Organization
Manufacturer of Goods
For Profit Organization
Manufacturer of Goods
State of Incorporation
IN
Country of Incorporation
USA
Employees
>1500
Reported NAICS
Accepts Credit Cards
Yes
People
Vendor contacts at Roche Diabetes Care
GSA Schedules and Price Lists
- Genentech Usa
- PoP: 9/14/23 - 9/14/28
- Obligated: $396,999,520
- Roche Diagnostics Corporation
- PoP: 5/14/22 - 5/14/27
- Type: Invitro Diagnostics, Reagents, Test Kits and Test Sets (FSS 65 VII)
- Obligated: $724,919
- View | Download
- Roche Diagnostics Corporation
- PoP: 3/15/17 - 3/15/27
- Type: Critical Analyzers, Laboratory, Cost-Per-Test (FSS 66 III)
- Obligated: $63,838,014
- View | Download
- Roche Diagnostics Corporation
- PoP: 5/14/11 - 5/14/26
- Type: Critical Analyzers, Laboratory, Cost-Per-Test (FSS 66 III)
- Obligated: $320,139,356
- View | Download
- Roche Diagnostics Corporation
- PoP: 8/31/09 - 8/31/24
- Type: Multiple Award Schedule (MAS)
- Obligated: $28,036,745
- View | Download
- Genentech Usa
- PoP: 9/29/16 - 9/14/23 (Ended)
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Obligated: $30,000,000
- Roche Diagnostics Corporation
- PoP: 9/30/11 - 9/30/21 (Ended)
- Obligated: $34,703,780
- View | Download
Contract Vehicles
Roche Diabetes Care multi-award contract vehicles
IDV Awards
Roche Diabetes Care indefinite delivery vehicle awards
Contract Awards
Roche Diabetes Care prime contract awards
Subcontract Awards
Roche Diabetes Care subcontract awards
Grant Awards
Roche Diabetes Care direct grants
Approved Supplier
CAGE 51169 Defense Logistics Agency approved NSNs
Teaming Partners
Disclosed awardee sub and prime contract and grant relationships
Roche Diabetes Care